CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 89 filers reported holding CULLINAN ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,673,707 | -15.9% | 626,929 | 0.0% | 0.21% | -26.0% |
| Q2 2023 | $6,745,756 | +5.2% | 626,929 | 0.0% | 0.29% | +73.5% |
| Q1 2023 | $6,413,484 | -3.0% | 626,929 | 0.0% | 0.17% | -42.4% |
| Q4 2022 | $6,614,101 | -7.8% | 626,929 | +12.0% | 0.29% | -20.2% |
| Q3 2022 | $7,176,000 | +88.2% | 559,737 | +88.2% | 0.36% | +80.5% |
| Q2 2022 | $3,812,000 | – | 297,347 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $69,216,825 | 18.48% |
| CHI Advisors LLC | 3,414,189 | $30,898,410 | 12.25% |
| Nextech Invest Ltd. | 1,221,145 | $11,051,362 | 3.35% |
| TANG CAPITAL MANAGEMENT LLC | 621,138 | $5,621,299 | 0.79% |
| BVF INC/IL | 3,196,701 | $28,930,144 | 0.78% |
| Parkman Healthcare Partners LLC | 438,745 | $3,970,642 | 0.73% |
| Velan Capital Investment Management LP | 75,000 | $678,750 | 0.55% |
| BRAIDWELL LP | 1,908,865 | $17,275,228 | 0.55% |
| Boxer Capital, LLC | 1,074,082 | $9,720,442 | 0.52% |
| DAFNA Capital Management LLC | 127,284 | $1,151,920 | 0.36% |